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Abstract The regulation of S6K1 by nutritional status and
insulin has been recently reported in vivo in chicken muscle
despite the relative insulin resistance of this tissue as estimated
by phosphatidylinositol 3-kinase (PI3-kinase) activity. The
present work aimed to study the impact of amino acids on
S6K1 activity in quail muscle (QM7) myoblasts. Firstly, we
characterized S6K1 in QM7 cells and demonstrated the absence
of insulin receptors in these cells. Secondly, we showed that
amino acids in the absence of insulin induced S6K1 phosphory-
lation on Thr389 and concomitantly increased its enzymatic
activity. Amino acid-induced S6K1 activation was inhibited by
LY294002 (PI3-kinase inhibitor) and rapamycin (inhibitor of
the mammalian target of rapamycin, mTOR), suggesting the
involvement of an avian homolog of mTOR. The availability
of individual amino acids (methionine or leucine) regulated
S6K1 phosphorylation on Thr389 and QM7 protein synthesis.
In conclusion, amino acids regulate S6K1 phosphorylation and
activity in QM7 cells through the mTOR/PI3-kinase pathway in
an insulin-independent manner.
5 2003 Federation of European Biochemical Societies. Pub-
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1. Introduction
The cytoplasmic serine/threonine kinase S6K1 plays a crit-
ical role in the regulation of protein translation in mammals.
S6K1 phosphorylates 40S ribosomal protein S6 and selectively
stimulates the translation of elongation factors and ribosomal
proteins [1]. This enzyme is activated through multisite phos-
phorylation in response to insulin via a signal transduction
pathway involving phosphatidylinositol 3-kinase (PI3-kinase)
and the mammalian target of rapamycin (mTOR) [2,3]. There
is also strong evidence of amino acid control of S6K1 through
a mechanism involving the mTOR signaling pathway. This
issue has been the subject of recent studies [4,5] but the under-
lying mechanisms remain to be elucidated. We have recently
shown that S6K1 is expressed in chicken muscle and demon-
strated its activation following refeeding and insulin treatment
in vivo [6]. S6K1 stimulation was observed despite the relative
resistance of chicken muscle to exogenous insulin [7] and the
lack of a refeeding-related response of chicken muscle PI3-
kinase [8].
The availability of an avian muscle cell line would represent
a useful tool to clarify the signal transduction pathway in-
volved in S6K1 activation in bird muscle. A stable and per-
manent myogenic cell line (QM7 cells) has been developed by
Antin and Ordahl [9]. QM7 cells were derived from a preex-
isting quail ¢brosarcoma cell line (QT6) cultured from meth-
ylcholanthrene-induced pectoralis ¢brosarcomas of Japanese
quail Coturnix coturnix japonica. To our knowledge this is
the only avian muscle cell line available thus far. In the
present study we showed the absence of insulin receptors on
the cell surface of QM7 cells leading us to use this cellular
model to investigate the regulation of S6K1 activity in re-
sponse to amino acids independently of insulin action.
2. Materials and methods
2.1. Materials
All culture media and additives were obtained from Gibco-BRL
(Life Technologies). Rabbit polyclonal anti-S6K1 was purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and anti-
phospho-Thr389 S6K1 was from Cell Signaling technology (Beverly,
MA, USA). The S6K1 assay kit was obtained from Upstate Cell
Signaling (Lake Placid, NY, USA). Monocomponent porcine insulin
was purchased from Novo Industrie Pharmaceutique (Paris, France).
Monoiodinated A-14 human 125I-labeled insulin and L-[U-14C]phenyl-
alanine (450 mCi/mmol) were from Amersham (Les Ulis, France).
[Q-33P]ATP was from NEN Life sciences (Zaventem, Belgium).
2.2. Cell culture and treatments
QM7 quail myoblast cells were grown in McCoy medium supple-
mented with 10% fetal calf serum and 1% chicken serum to 90^100%
con£uence, fasted 24 h in serum-free medium, washed once with ami-
no acid-deprived medium (Earle’s balanced salt solution containing
MEM vitamins and 2 g/l glucose), and incubated in the same medium
for 2 h. Cells were then incubated in fresh medium containing various
concentrations of amino acids as indicated in each experiment. The
1Uconcentration of amino acids (MEM as reference) was de¢ned as
the following (in mM): L-arginine HCl 1.1, L-cysteine 0.2, L-histidine
HCl H2O 0.2, L-isoleucine 0.4, L-leucine 0.4, L-lysine HCl 0.4, L-me-
thionine 0.1, L-phenylalanine 0.2, L-threonine 0.4, L-tryptophan 0.05,
L-tyrosine 0.2, L-valine 0.4, L-alanine 0.2, L-asparagine 0.2, L-aspartic
acid 0.2, L-glutamic acid 0.2, glycine 0.2, L-proline 0.2, L-serine 0.2,
L-glutamine 2.0. NaCl was added as needed to maintain equal osmo-
larity. In some studies, complete RPMI medium or RPMI media
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without methionine or leucine were used instead of the above-men-
tioned media.
2.3. Western blotting
At the end of incubation, QM7 myoblasts were prepared as previ-
ously described [10]. S6K1 activation was determined by gel mobility
shift assays. The phosphorylated active form of the kinase is deter-
mined as a band with lower mobility on SDS^PAGE and the unphos-
phorylated form, which corresponds to the inactive form, as a band
with higher mobility. Aliquots of supernatant (10 Wg protein, assessed
using a Bio-Rad kit) were separated on 7.5% SDS^PAGE and West-
ern blotting as previously described [6]. For S6K1 phosphorylation on
Thr389, 20 Wg of QM7 proteins were separated on 10% SDS^PAGE
and Western blotting using an anti-phospho-Thr389 S6K1 polyclonal
antibody according to the manufacturer’s procedure. The antibody
also detects a band of 85 kDa corresponding to the nuclear S6K1
isoform (p85S6K1). Bands were visualized by enhanced chemilumines-
cence and quanti¢ed by Scion Image software. The S6K1 phosphor-
ylation intensity was normalized for S6K1 content determined using a
rabbit anti-S6K1 polyclonal antibody.
2.4. S6K1 assay
S6K1 activity was measured by immune kinase assay according to
the procedure in the S6K1 assay kit. Brie£y, QM7 lysates were im-
munoprecipitated with anti-S6K1 antibody and the speci¢c enzyme
activity of the protein was measured by estimating the phosphoryla-
tion of an arti¢cial substrate (AKRRRLSSLRA) corresponding to an
11 amino acid sequence of the ribosomal protein S6 in the presence of
labeled ATP.
2.5. Insulin binding to chicken liver and QM7 cell membranes
A liver sample taken from 3-week-old chickens was used as refer-
ence. After the chicken was killed, the liver sample was immediately
frozen, ground in liquid nitrogen and stored at 380‡C. The crude
liver membranes were prepared by di¡erential centrifugation as pre-
viously described [11]. For QM7 crude membrane preparation, con-
£uent cells were extensively washed in ice-cold phosphate-bu¡ered
saline (PBS) and frozen for 24 h at 380‡C; cells were then scraped
from the culture dishes in the presence of cold membrane bu¡er con-
taining protease and phosphatase inhibitors. The resulting mixture
was treated as previously described for liver membrane preparation.
Insulin binding was determined as previously described [11].
2.6. Protein synthesis
In order to measure protein synthesis in QM7 myoblasts, L-[U-14C]-
phenylalanine (0.25 WCi/ml) was added to the medium during the
stimulation period. At the end of incubation (60 min), cells were
washed once in ice-cold PBS, and then in ice-cold 10% trichloroacetic
acid (TCA). TCA-insoluble material was washed three times with 10%
TCA and solubilized in 0.5 M NaOH at 37‡C for determination of
protein (BCA, Pierce) and radioactivity incorporated into QM7 pro-
tein. Protein synthesis was expressed as nmol phenylalanine incorpo-
rated per mg protein/h [12].
2.7. Statistical analysis
Statistical analysis was performed using analysis of variance (Stat-
view Software program, version 5) to detect signi¢cant intergroup
di¡erences. Values are expressed as meansUS.E.M., and P6 0.05
was considered statistically signi¢cant.
3. Results and discussion
3.1. Insulin binding to QM7 membranes
The presence of insulin receptors in QM7 cells was inves-
tigated using iodinated insulin. Speci¢c 125I-labeled insulin
binding to QM7 cell membranes and to liver membranes (con-
trol) was measured following 20 h incubation at 4‡C. Fig. 1
indicates the absence of speci¢c insulin binding to QM7 cell
membranes. Similar results were obtained when insulin bind-
ing to QM7 cells was estimated on intact monolayer cells
(data not shown). These ¢ndings reveal that the QM7 cell
line is lacking insulin receptors.
3.2. E¡ects of amino acids on S6K1 phosphorylation
To study the impact of amino acid availability, QM7 cells
were transferred to McCoy medium without serum for 7 h,
then subjected to amino acid deprivation for 1 h. Amino acid
deprivation reduced the phosphorylation of S6K1 as shown
by the higher mobility of the protein on SDS^PAGE as com-
pared to cells cultured in medium containing amino acids
(Fig. 2A). This e¡ect was reversed by re-supplying amino
acids for 30 min, with a clear decrease in the electrophoretic
mobility of S6K1 indicative of phosphorylation of the protein
(Fig. 2B). In addition, we found that the S6K1 band was
shifted for the lower amino acid concentrations (0.25 and
0.5U) corresponding to activation of the enzyme at physio-
logical concentrations.
Fig. 1. 125I-labeled insulin binding to chicken liver and QM7 cell
membranes. Speci¢c 125I-labeled insulin binding to liver and QM7
cell membranes was inhibited by increasing concentrations of unla-
beled insulin, using the same membrane protein concentration (0.4
mg/ml, ¢nal concentration). The speci¢c binding of labeled insulin
(B) is expressed as the percentage of total (T). Data were obtained
with QM7 cells originating from two independent experiments and
triplicate determinations were performed per curve point.
 
Fig. 2. E¡ects of amino acid deprivation and addition on S6K1
phosphorylation. A: Representative S6K1 gel mobility shift assay.
QM7 cells were cultured in McCoy medium, fasted for 7 h, and
subjected to amino acid deprivation for 1 h. B: Representative
S6K1 gel mobility shift assay (of three independent experiments).
QM7 cells were cultured in McCoy medium, fasted for 24 h, and
subjected to amino acid deprivation for 2 h. The culture medium
was replaced with amino acid-free medium or amino acid mixtures
ranging in concentration from 0.25 to 2U (MEM as reference) for
30 min.
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3.3. E¡ects of amino acid concentration on Thr389
phosphorylation and S6K1 activity
We next investigated the e¡ects of amino acid concentration
on S6K1 phosphorylation on residue Thr389. As shown in
Fig. 3A, the mobility shift induced by amino acids was clearly
associated with an increase in Thr389 phosphorylation level.
Amino acids also increased S6K1 activity, in a dose-depen-
dent manner (Fig. 3B). A signi¢cant increase was already
observed with the lower amino acid concentrations
(0.125U). The phosphorylation and activation of S6K1 in-
duced by amino acids is in good agreement with data ob-
tained in mammals [13^17]. The positive correlation between
S6K1 activity and its phosphorylation on residue Thr389 is
also consistent with the assumption that the phosphorylation
of Thr389 is necessary for S6K1 activation [18,19].
3.4. E¡ects of LY294002 and rapamycin on amino acid-induced
S6K1 activation
To explore the signaling pathway involved in amino acid-
induced S6K1 activation, QM7 cells were incubated with or
without treatment with 50 WM LY294002 (PI3-kinase inhib-
itor) or 100 nM rapamycin (speci¢c mTOR inhibitor) for 1 h.
Gel mobility shift assays showed that the increased phosphor-
ylation of S6K1 by amino acids was blocked by both
LY294002 and rapamycin (Fig. 4A). Similarly, the inhibitors
completely abolished the amino acid-stimulated S6K1 activity
(Fig. 4B). Our results therefore indicate that the rapamycin-
sensitive pathway involving an avian homolog of mTOR is
required. The present study also demonstrates an inhibitory
e¡ect of LY294002 in QM7 cells. It is possible that, at the
concentration used in this study, LY294002 inhibits mTOR
[20]. However, numerous papers have reported that both
mTOR and other members of the PI3-kinase family are in-
volved in amino acid-induced activation of S6K1 in mamma-
lian cells [13,15,16,21,22]. Therefore, the activation of S6K1
implies mTOR and/or PI3-kinase pathways in QM7 cells.
3.5. E¡ects of methionine and leucine availability on S6K1
phosphorylation and on protein synthesis assessed by
phenylalanine incorporation
The impact of amino acid composition on S6K1 activation
was further investigated by incubating QM7 cells for 2 h in
RPMI medium lacking methionine or leucine followed by the
addition of the deprived amino acids for 1 h. Methionine or
leucine deprivation caused a decrease in S6K1 phosphoryla-
tion on Thr389 compared to control cells (335 and 350% for
methionine and leucine deprivation, respectively: P6 0.05;
Fig. 5A). The supply of the lacking amino acid restored phos-
phorylation status to the level observed in control cells. In
cells deprived of leucine to which the deprived amino acid
was returned at half concentration, phosphorylation status
was also signi¢cantly increased and reached a level similar
to controls. Thus, S6K1 was activated by leucine and methio-
nine in avian species as in mammals [22^25]. In addition,
Fig. 3. E¡ects of amino acid concentration on S6K1 phosphorylation and activity. QM7 cells were cultured in McCoy medium, fasted for 24 h,
and subjected to amino acid deprivation for 2 h. The culture medium was replaced with amino acid-free medium or amino acid mixtures rang-
ing in concentration from 0.125 to 2U (MEM as reference) for 30 min. A: S6K1 phosphorylation on Thr389. Results of a representative S6K1
gel mobility shift assay are shown in the inset. B: S6K1 immune complex assay. Data are meansUS.E.M. (n=6^7) from four independent ex-
periments and are expressed as fold stimulation above basal level (amino acid-free medium). adMeans not sharing the same letter are signi¢-
cantly di¡erent (P6 0.05).
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methionine and leucine availability concomitantly regulated
QM7 protein synthesis (Fig. 5B). Deprivation of methionine
or leucine reduced protein synthesis compared to control cells
(approximately 340 and 330% for methionine and leucine
deprivation, respectively, P6 0.001) whereas their incorpora-
tion into culture media returned protein synthesis to control
values. Taken together, our results demonstrate the role of
leucine and methionine in S6K1 activation and in mediating
stimulation in protein synthesis in QM7 myoblasts. Interest-
ingly, the QM7 cell line is highly sensitive to amino acid
availability and changes in culture media.
In conclusion, S6K1 is expressed in the quail muscle (QM7)
cell line. This kinase is regulated by amino acid availability
through signal transduction pathways involving mTOR and/
or PI3-kinase independently of insulin. Additional studies on
mTOR/PI3-kinase signaling pathways in QM7 cells are
needed and may contribute to the understanding of the po-
tential insulin resistance observed in chicken muscle.
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